Kliman Gilbert H — SEC insider filings
SEC reporting owner CIK 1293171. 47 insider filings on record with FilingPulse; latest filed 2026-11-05.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2020-09-29 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 110,555 shares, $1,989,990 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 23 legs across 18 filings — 5,540,851 shares, $186,119,324 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 122.
- Largest priced transaction: sale of 4,289,250 shares @ $24.57 ($105,386,872) in Doximity, Inc., filed 2021-06-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Doximity, Inc. (DOCS) | — | 7 | — | 6 legs · 4,336,142 sh · $108,135,867 | 20 |
| Braze, Inc. (BRZE) | 10% owner | 2 | — | 1 leg · 1,130,000 sh · $69,404,600 | 10 |
| GLAUKOS Corp (GKOS) | Director | 27 | — | 16 legs · 74,709 sh · $8,578,857 | 51 |
| PMV Pharmaceuticals, Inc. (PMVP) | 10% owner | 5 | 2 legs · 110,555 sh · $1,989,990 | — | 34 |
| STAAR SURGICAL CO (STAA) | Director | 6 | — | — | 7 |
Insider filings — Kliman Gilbert H
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-05 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 2,500 @ $25.77 · Sale (S): 2,500 @ $253 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-08-20 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 2,500 @ $25.77 · Sale (S): 2,500 @ $190 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4/A | GLAUKOS Corp (GKOS) | Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,878 @ $0 · Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 5,000 @ $24.69 · Sale (S): 5,000 @ $140.76 · Option exercise (M): 5,000 (derivative) @ $24.69 | EDGAR |
| 2026-05-13 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 5,000 @ $24.69 · Sale (S): 5,000 @ $135 · Option exercise (M): 5,000 (derivative) @ $24.69 | EDGAR |
| 2026-01-07 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 623 @ $0 | EDGAR |
| 2025-12-11 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 5,000 @ $24.69 · Sale (S): 5,000 @ $107.27 · Option exercise (M): 5,000 (derivative) @ $24.69 | EDGAR |
| 2025-06-02 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 461 @ $0 · Grant/award (A): 2,108 @ $0 · Grant/award (A): 3,149 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 10,000 @ $32 · Sale (S): 10,000 @ $150.28 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 2,000 @ $32 · Sale (S): 2,000 @ $144.01 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 3,000 @ $32 · Sale (S): 2,000 @ $131 · Sale (S): 1,000 @ $130 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 5,000 @ $32 · Sale (S): 5,000 @ $112 · Grant/award (A): 1,716 @ $0 · Option exercise (M): 5,000 (derivative) @ $0 · Grant/award (A): 1,246 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | GLAUKOS Corp (GKOS) | Sale (S): 3,145 @ $86.01 · Sale (S): 5,202 @ $84.93 · Option exercise (M): 5,000 @ $32 · Sale (S): 5,000 @ $88.25 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | GLAUKOS Corp (GKOS) | Sale (S): 8,000 @ $92 | EDGAR |
| 2024-01-04 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 895 @ $0 | EDGAR |
| 2023-12-05 | 4 | STAAR SURGICAL CO (STAA) | Holdings only — no transactions reported | EDGAR |
| 2023-12-04 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 366 @ $32.99 | EDGAR |
| 2023-10-03 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 435 @ $40.18 | EDGAR |
| 2023-08-08 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 10,000 @ $7.28 · Sale (S): 10,000 @ $74.56 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | STAAR SURGICAL CO (STAA) | Option exercise (M): 3,417 @ $0 | EDGAR |
| 2023-06-05 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 3,230 @ $0 | EDGAR |
| 2023-01-04 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,572 @ $0 | EDGAR |
| 2022-08-19 | 4 | GLAUKOS Corp (GKOS) | Other (J): 2,382 @ $0 · Other (J): 2,382 @ $0 | EDGAR |
| 2022-08-08 | 4 | GLAUKOS Corp (GKOS) | Other (J): 333,917 @ $0 · Other (J): 83,955 @ $0 · Other (J): 83,955 @ $0 · Other (J): 19,045 @ $0 · Sale (S): 3,362 @ $53.01 | EDGAR |
| 2022-08-05 | 4 | Doximity, Inc. (DOCS) | Disposition to issuer (D): 4,714 | EDGAR |
| 2022-07-29 | 4 | Doximity, Inc. (DOCS) | Grant/award (A): 4,714 @ $0 | EDGAR |
| 2022-06-17 | 4 | STAAR SURGICAL CO (STAA) | Option exercise (M): 355 @ $0 · Option exercise (M): 2,899 @ $0 | EDGAR |
| 2022-06-06 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 4,364 @ $0 | EDGAR |
| 2022-05-18 | 4 | GLAUKOS Corp (GKOS) | Other (J): 980 @ $0 · Other (J): 980 @ $0 | EDGAR |
| 2022-02-25 | 4 | Doximity, Inc. (DOCS) | Sale (S): 29,174 @ $56.09 · Sale (S): 826 @ $59 | EDGAR |
| 2022-02-09 | 4 | Braze, Inc. (BRZE) jointly with InterWest Management Partners X, LLC, INTERWEST PARTNERS X LP, NASR KHALED, Desai Keval | Conversion (C): 3,394,219 · Conversion (C): 3,394,219 (derivative) @ $0 | EDGAR |
| 2021-12-08 | 4 | Doximity, Inc. (DOCS) | Sale (S): 8,912 @ $63 · Sale (S): 5,980 @ $62 | EDGAR |
| 2021-12-06 | 4 | Doximity, Inc. (DOCS) | Conversion (C): 4,300,000 · Other (J): 4,300,000 @ $0 · Other (J): 1,101,094 @ $0 · Other (J): 1,101,094 @ $0 · Other (J): 249,778 @ $0 · Sale (S): 2,000 @ $65.82 · +1 more | EDGAR |
| 2021-11-23 | 4 | Braze, Inc. (BRZE) jointly with InterWest Management Partners X, LLC, INTERWEST PARTNERS X LP, NASR KHALED, Desai Keval | Conversion (C): 4,524,219 · Other (J): 4,524,219 · Conversion (C): 1,130,000 · Sale (S): 1,130,000 @ $61.42 · Conversion (C): 2,824,395 (derivative) @ $0 · Conversion (C): 1,603,848 (derivative) @ $0 · +3 more | EDGAR |
| 2021-11-15 | 4 | Doximity, Inc. (DOCS) | Conversion (C): 4,300,000 · Other (J): 4,300,000 @ $0 · Other (J): 1,089,179 @ $0 · Other (J): 1,089,179 @ $0 · Other (J): 247,074 @ $0 · Conversion (C): 4,300,000 (derivative) @ $0 | EDGAR |
| 2021-09-10 | 4 | GLAUKOS Corp (GKOS) | Other (J): 3,900 @ $0 · Other (J): 3,900 @ $0 | EDGAR |
| 2021-07-14 | 4 | PMV Pharmaceuticals, Inc. (PMVP) jointly with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, NASR KHALED, Desai Keval | Other (J): 500,000 @ $0 · Other (J): 97,632 @ $0 · Other (J): 97,632 @ $0 · Other (J): 3,642 @ $0 · Other (J): 2,441 @ $0 · Other (J): 22,148 @ $0 | EDGAR |
| 2021-06-28 | 4 | Doximity, Inc. (DOCS) | Conversion (C): 4,289,250 · Sale (S): 4,289,250 @ $24.57 · Conversion (C): 13,296,504 (derivative) @ $0 · Conversion (C): 5,412,972 (derivative) @ $0 · Conversion (C): 2,736,772 (derivative) @ $0 · Conversion (C): 21,446,248 (derivative) @ $0 · +1 more | EDGAR |
| 2021-06-25 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 404 @ $0 · Option exercise (M): 850 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 2,382 @ $0 | EDGAR |
| 2021-05-12 | 4 | PMV Pharmaceuticals, Inc. (PMVP) jointly with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, NASR KHALED, Desai Keval | Other (J): 500,000 @ $0 · Other (J): 5,000 @ $0 · Other (J): 5,000 @ $0 · Other (J): 186 @ $0 · Other (J): 125 @ $0 · Other (J): 1,135 @ $0 | EDGAR |
| 2021-03-25 | 4 | PMV Pharmaceuticals, Inc. (PMVP) jointly with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, NASR KHALED, Desai Keval | Other (J): 1,000,000 @ $0 · Other (J): 10,000 @ $0 · Other (J): 10,000 @ $0 · Other (J): 373 @ $0 · Other (J): 250 @ $0 · Other (J): 2,269 @ $0 | EDGAR |
| 2021-03-05 | 4 | GLAUKOS Corp (GKOS) | Other (J): 300,000 @ $0 · Other (J): 3,000 @ $0 · Other (J): 3,000 @ $0 · Other (J): 680 @ $0 | EDGAR |
| 2021-01-06 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 980 @ $0 | EDGAR |
| 2020-10-02 | 4/A | PMV Pharmaceuticals, Inc. (PMVP) jointly with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, NASR KHALED, Desai Keval | Purchase (P): 55,555 @ $18 · Conversion (C): 1,620,101 · Conversion (C): 3,488,398 · Conversion (C): 1,040,654 · Conversion (C): 265,203 · Conversion (C): 1,620,101 (derivative) @ $0 · +3 more | EDGAR |
| 2020-09-29 | 4 | PMV Pharmaceuticals, Inc. (PMVP) jointly with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, NASR KHALED, Desai Keval | Purchase (P): 55,000 @ $18 · Conversion (C): 1,620,101 · Conversion (C): 3,488,398 · Conversion (C): 1,040,654 · Conversion (C): 265,203 · Conversion (C): 1,620,101 (derivative) @ $0 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1293171 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs